Sandra Levy
ARTICLES BY THIS AUTHOR
- 10/11/2021
Hikma intros micafungin for injection
Micafungin for injection had a market value of $132 million in the 12 months ended August 2021, according to IQVIA. - 10/11/2021
Retailers bolster specialty pharmacy capabilities as its role in the industry grows
Specialty pharmacy provides customers with a wide range of services, including in-depth monitoring and patient counseling, as well as reimbursement assistance. - 10/11/2021
Ira Katz receives 2021 NCPA Willard B. Simmons Independent Pharmacist of the Year Award
Katz is known for his tireless effort in combating the opioid epidemic in his community, the organization said. - 10/11/2021
Dan Leonard reflects on first year at helm of AAM
Dan Leonard is celebrating his first year as president and CEO of the Association for Accessible Medicines. - 10/11/2021
Bartell Drugs partners with Shipt to launch same-day delivery in Washington
Bartell Drugs shoppers in Washington’s King, Snohomish and Pierce counties can now get delivery through the Shipt marketplace in as soon as one hour. - 10/11/2021
Standout specialty services
Innovative offerings from The Compliance Team, Knapp, LexisNexis Risk Solutions and Surescripts are available to help specialty retailers. - 10/11/2021
PTCB launches point-of-care testing credential for pharmacy technicians
Technicians who earn the PTCB Point-of-Care Testing Certificate demonstrate their advanced knowledge in screening patients, administering tests, collecting specimens, and reading and recording test results. - 10/10/2021
Merck, Ridgeback seeks FDA emergency use clearance for COVID-19 treatment
If approved, molnupiravir would be the first oral antiviral pill for the treatment of mild-to-moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and/or hospitalization. - 10/10/2021
NCPA Annual Convention honors pharmacists, students
The organization honored outstanding students and pharmacists at its 2021 Annual Convention, which was held in person. - 10/10/2021
BioCareSD to provide 2 new specialty medications
Specialty distributor BioCareSD is offering Tepezza and Krystexxa, which offer treatment for thyroid eye disease and chronic gout, respectively.
